Endocrine Disruptors and Obesity: An Overview.
Murro I, Lisco G, Di Noia C, Lampignano L, Zupo R, Giagulli VA, Guastamacchia E, Triggiani V, De Pergola G.
Murro I, et al.
Endocr Metab Immune Disord Drug Targets. 2022;22(8):798-806. doi: 10.2174/1871530322666220328122300.
Endocr Metab Immune Disord Drug Targets. 2022.
PMID: 35346017